# CoverCress

> Gene-edited winter oilseed (pennycress) crop for low-carbon fuel feedstock and cover-crop benefits.

## Why it is interesting

St. Louis agtech exit signal: Bayer acquired a 65% majority stake (Aug 2022), with Bunge and Chevron retaining 35% — farm-to-fuel CoverCress™ winter oilseed commercialized from field pennycress.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** other
- **Status:** acquired
- **Industries:** climate-tech, biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-07-26

## Key facts

- Bayer acquired 65% majority stake (Aug 2022); Bunge and Chevron retain 35% (Bayer / BioSTL)
- Winter oilseed from gene-edited field pennycress for renewable fuel + cover-crop benefits
- Founded 2013 as Arvegenix by Monsanto alumni; St. Louis HQ
- Operates as standalone entity post majority acquisition

## Funding history

- Majority acquisition (Bayer 65%) · August 2022
  Source: https://www.bayer.com/media/en-us/bayer-expands-existing-investment-to-acquire-majority-share-in-sustainable-lower-carbon-oilseed-producer-covercress-inc/

## Related articles

- https://venturecapitaltracker.com/st-louis-startups-and-vc-firms-2026

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** July 26, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/covercress